SynopsisThe global Ventricular Natriuretic Peptide Test market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Ventricular Natriuretic Pepti.....
SynopsisThe global Brain Natriuretic Peptide (BNP) Test market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Brain Natriuretic Peptide (BN.....
SynopsisThe global B-type Natriuretic Peptide Test market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for B-type Natriuretic Peptide Test is.....
SynopsisThe global Natriuretic Peptides Test market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Natriuretic Peptides Test is estimated t.....
SynopsisThe global N-terminal Pro B-type Natriuretic Peptide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for N-terminal Pro B-type Na.....
SynopsisThe global NASH Therapeutic Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing.....
SynopsisThe global Non-Alcoholic Steatohepatitis (NASH) Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 bill.....
SynopsisThe global PD-1 and PD-L1 Antibody market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for PD-1 and PD-L1 Antibody is estimated to in.....
SynopsisThe global PD-1 and PD-L1 Immunotherapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for PD-1 and PD-L1 Immunotherapy is estim.....
SynopsisThe global GLP-1R Agonist market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for GLP-1R Agonist is estimated to increase from $ mill.....
